Management of iron deficiency in chronic kidney disease: Focus review and proposed algorithm (notice n° 192078)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01903cam a2200181 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112044754.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Guibergia, Corinne |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Management of iron deficiency in chronic kidney disease: Focus review and proposed algorithm |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2022.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 86 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Iron deficiency is very common in chronic kidney disease, even before the dialysis stage. It is an independent factor of morbidity and mortality in patients with non-dialysis-dependent chronic kidney disease. In patients with chronic kidney disease, iron deficiency is defined by a transferrin saturation 100 μg/L). Despite this, iron deficiency is usually not investigated: over 60% of nephrologists do not assess iron status at least once a year. Iron deficiency is also rarely treated, with only 12% of patients prescribed oral or intravenous iron. Early detection and treatment are fundamental and should be done routinely. To help improve the management of iron deficiency among patients with non-dialysis-dependent chronic kidney disease, we propose an algorithm that takes into account current recommendations and the most recent data from the literature. The initial blood tests should measure hemoglobin concentration, transferrin saturation, and serum ferritin. A transferrin saturation <20% establishes the diagnosis of iron deficiency and the serum ferritin level points toward an absolute or functional deficiency. The combination of both values makes it possible to adapt treatment, particularly in an inflammatory context where oral iron is not effective. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brazier, François |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Choukroun, Gabriel |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Néphrologie & Thérapeutique | Volume 18 | 7 | 2022-07-26 | p. 658-665 | 1769-7255 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-nephrologie-therapeutique-2022-7-page-658?lang=en">https://shs.cairn.info/journal-nephrologie-therapeutique-2022-7-page-658?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux